ADC Therapeutics SA ADCT:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
7.97UNCH (UNCH)
Volume
508
Close
7.97quote price arrow down-0.08 (-0.99%)
Volume
219,036
52 week range
5.52 - 32.00
Loading...
  • Open7.87
  • Day High8.08
  • Day Low7.64
  • Prev Close8.05
  • 52 Week High32.00
  • 52 Week High Date11/02/21
  • 52 Week Low5.52
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap612.18M
  • Shares Out76.81M
  • 10 Day Average Volume0.28M
  • Dividend-
  • Dividend Yield-
  • Beta1.12
  • YTD % Change-60.54

KEY STATS

  • Open7.87
  • Day High8.08
  • Day Low7.64
  • Prev Close8.05
  • 52 Week High32.00
  • 52 Week High Date11/02/21
  • 52 Week Low5.52
  • 52 Week Low Date06/16/22
  • Market Cap612.18M
  • Shares Out76.81M
  • 10 Day Average Volume0.28M
  • Dividend-
  • Dividend Yield-
  • Beta1.12
  • YTD % Change-60.54

RATIOS/PROFITABILITY

  • EPS (TTM)-2.54
  • P/E (TTM)-3.13
  • Fwd P/E (NTM)-2.32
  • EBITDA (TTM)-236.873M
  • ROE (TTM)-84.74%
  • Revenue (TTM)80.42M
  • Gross Margin (TTM)97.61%
  • Net Margin (TTM)-242.69%
  • Debt To Equity (MRQ)188.52%

EVENTS

  • Earnings Date08/09/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ADC Therapeutics SA

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
ADC Therapeutics SA is a Switzerland-based clinical-stage oncology drug discovery and development company. It develops antibody drug conjugates (ADCs) for the treatment of both solid and hematological cancers. It employs monoclonal antibodies specific to particular tumor antigens conjugated to a class of pyrrolobenzodiazepine (PBD)-based warheads to selectively target and kill cancer cells. The Company has multiple PBD-based ADCs in ongoing clinical trials, ranging from first...
Michael Forer
Vice Chairman of the Board, Executive Vice President, General Counsel
Ron Squarer
Non-Executive Chairman of the Board
Christopher Martin Ph.D.
Chief Executive Officer, Executive Director
Jennifer Creel
Chief Financial Officer
Robert Schmidt
Vice President, Corporate Controller & Chief Accounting Officer
Lisa Skelton Ph.D.
Vice President - Global Project Management
Address
Biopole, route de la Corniche 3B
Epalinges
1066
Switzerland

Top Peers

SYMBOLLASTCHG%CHG
CCCC
C4 Therapeutics Inc
11.70-0.54-4.41%
TBPH
Theravance Biopharma Inc
9.00+0.08+0.90%
SGMO
Sangamo Therapeutics Inc
5.24-0.05-0.95%
CARA
Cara Therapeutics Inc
11.81+0.31+2.70%
ADMA
ADMA Biologics Inc
2.03-0.04-1.93%